6-Amino-2-(butylamino)-9-[[6-[2-(dimethylamino)ethoxy]-3-pyridinyl]methyl]-7,9-dihydro-8H-purin-8-one, 100mg

2-Cyanothiazole, 95.0%, 1g

3-(4-Fluorophenyl)isoxazole-5-carbaldehyde, 98%, 1g

2-[[[(Tetrahydro-2-furanyl)methyl]amino]methyl]phenol, 98%, 250mg

2-chloro-1-(1-(2,5-difluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl)ethan-1-one, 95.0%, 250mg

ETHYL 4-BROMO-1-NAPHTHOATE, 95%, 5g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 50 m, Ø-Innen 0,20 mm, Filmd. 0,20 µm, 1 Stück

2-Methyl-6-(trifluoromethyl)pyridin-3-amine, 95.0%, 5g

3-(4-Carboxyphenyl)propionic acid, 98.0%, 100g

6-chloro-3-methyl-2H-pyrazolo[3,4-d]pyrimidine, 97%, 5g

1-Bromo-4-methoxybutane, 99.0%, 1g

(2S,3R,4S,5R,6R)-2-((6-fluoro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 95+%, 25mg

4-[(methoxyacetyl)amino]benzoic acid, 95.0%, 5g